PL2714658T3 - Nowe inhibitory cholinoesteraz o strukturze hybrydowej - Google Patents
Nowe inhibitory cholinoesteraz o strukturze hybrydowejInfo
- Publication number
- PL2714658T3 PL2714658T3 PL12730282T PL12730282T PL2714658T3 PL 2714658 T3 PL2714658 T3 PL 2714658T3 PL 12730282 T PL12730282 T PL 12730282T PL 12730282 T PL12730282 T PL 12730282T PL 2714658 T3 PL2714658 T3 PL 2714658T3
- Authority
- PL
- Poland
- Prior art keywords
- cholinesterase inhibitors
- novel hybrid
- hybrid
- novel
- cholinesterase
- Prior art date
Links
- 239000000544 cholinesterase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL395113A PL219106B1 (pl) | 2011-06-03 | 2011-06-03 | Nowe inhibitory cholinoesteraz o strukturze hybrydowej |
| PL398731A PL221154B1 (pl) | 2012-04-04 | 2012-04-04 | Inhibitory cholinoesteraz o strukturze hybrydowej, sposób ich otrzymywania, ich zastosowanie oraz preparat farmaceutyczny je zawierający |
| EP20120730282 EP2714658B1 (en) | 2011-06-03 | 2012-05-29 | Novel hybrid cholinesterase inhibitors |
| PCT/PL2012/000038 WO2012165981A1 (en) | 2011-06-03 | 2012-05-29 | Novel hybrid cholinesterase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2714658T3 true PL2714658T3 (pl) | 2015-09-30 |
Family
ID=46395682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12730282T PL2714658T3 (pl) | 2011-06-03 | 2012-05-29 | Nowe inhibitory cholinoesteraz o strukturze hybrydowej |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8841453B2 (pl) |
| EP (1) | EP2714658B1 (pl) |
| ES (1) | ES2539178T3 (pl) |
| PL (1) | PL2714658T3 (pl) |
| WO (1) | WO2012165981A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111727040A (zh) * | 2018-02-19 | 2020-09-29 | 纳特雷恩公司 | 用于改善认知能力或认知功能的尿石素a和b的协同组合 |
| CN108840864B (zh) * | 2018-07-31 | 2021-07-27 | 中国医学科学院生物医学工程研究所 | 一种他克林-杂环轭联物的制备方法及用途 |
| CN111592530B (zh) * | 2020-05-18 | 2021-09-24 | 山东大学 | 含醛肟的他克林衍生物类选择性丁酰胆碱酯酶抑制剂及其制备方法和应用 |
| CN113387867B (zh) * | 2021-07-15 | 2023-03-14 | 南华大学 | 一种氨基甲酸酯类邻氨基苯甲酸色胺衍生物及其制备与应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0223494D0 (en) | 2002-10-09 | 2002-11-13 | Neuropharma Sa | Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease |
| GB0316094D0 (en) | 2003-07-09 | 2003-08-13 | Neuropharma Sa | Acetylcholinesterase dual inhibitors |
-
2012
- 2012-05-29 EP EP20120730282 patent/EP2714658B1/en not_active Not-in-force
- 2012-05-29 ES ES12730282.6T patent/ES2539178T3/es active Active
- 2012-05-29 PL PL12730282T patent/PL2714658T3/pl unknown
- 2012-05-29 WO PCT/PL2012/000038 patent/WO2012165981A1/en not_active Ceased
-
2013
- 2013-11-22 US US14/087,744 patent/US8841453B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2714658B1 (en) | 2015-04-29 |
| US8841453B2 (en) | 2014-09-23 |
| WO2012165981A1 (en) | 2012-12-06 |
| ES2539178T3 (es) | 2015-06-26 |
| US20140080860A1 (en) | 2014-03-20 |
| EP2714658A1 (en) | 2014-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201307225B (en) | Methods for genomic modification | |
| HUE046097T2 (hu) | Átvezetés | |
| AP3529A (en) | Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors | |
| ZA201403050B (en) | R(+)-n-methyl-propargyl-aminoindan | |
| ZA201306989B (en) | Dividable tray | |
| GB201104265D0 (en) | Pack | |
| ZA201403043B (en) | R(+)-n-formyl-propargyl-aminoindan | |
| IL231269A0 (en) | Preparations for the treatment of HIV | |
| PL2714658T3 (pl) | Nowe inhibitory cholinoesteraz o strukturze hybrydowej | |
| AU4555P (en) | WES02 Westringia hybrid | |
| AU5371P (en) | CorBzr01 Cordyline hybrid | |
| AU5170P (en) | Sunpararenga Mandevilla hybrid | |
| AU5109P (en) | Nuflordyna Gazania hybrid | |
| AU4831P (en) | Sunparavel Mandevilla hybrid | |
| AU4554P (en) | WES03 Westringia hybrid | |
| PL395113A1 (pl) | Nowe inhibitory cholinoesteraz o strukturze hybrydowej | |
| AU4578P (en) | Q245 Saccharum hybrid | |
| AU4646P (en) | Q248 Saccharum hybrid | |
| AU4580P (en) | Q247 Saccharum hybrid | |
| AU4577P (en) | Q244 Saccharum hybrid | |
| AU4579P (en) | Q246 Saccharum hybrid | |
| AU2011308V (en) | Agapetite Agapanthus hybrid | |
| AU2011267V (en) | KLEAC11211 Anigozanthos hybrid | |
| AU2011269V (en) | KLEAC11213 Anigozanthos hybrid | |
| AU2011268V (en) | KLEAC11212 Anigozanthos hybrid |